Kimberly-Clark's Stock Falls Amid Restructuring Efforts
ByAinvest
Thursday, Aug 21, 2025 10:09 am ET1min read
KMB--
On August 19, 2025, Slocum, Gordon & Co LLP reported selling all 20,789 shares of Kimberly-Clark Corporation (NASDAQ:KMB) during the second quarter. The estimated transaction value, based on the quarterly average price for Q2 2025, was approximately $2.96 million. This move reduced the fund’s position in Kimberly-Clark to zero as of June 30, 2025.
The top holdings after the filing include Procter & Gamble, NextEra Energy, Exxon Mobil, and Merck. Kimberly-Clark shares were priced at $131.33 as of August 18, 2025, with a 1-year price drop of 8.46%. The shares underperformed the S&P 500 by 23.5 percentage points over this period. The company's dividend yield stands at 3.74%, with a forward P/E ratio of 17.34 and an EV/EBITDA (TTM) of 13.0 (as of 2025-06-30). The shares were down 11.9% from their 52-week high as of 2025-08-18.
Kimberly-Clark manufactures and markets personal care and tissue products under brands such as Huggies, Kleenex, and Scott. The company generates revenue primarily through direct sales to supermarkets, mass merchandisers, drugstores, warehouse clubs, and e-commerce platforms, as well as via distributors for both household and away-from-home use. It serves retail consumers globally and commercial clients in sectors including manufacturing, lodging, office buildings, and food service.
References
[1] https://www.marketbeat.com/stocks/NYSE/T/institutional-ownership/
[2] https://www.nasdaq.com/articles/slocum-gordon-exits-stake-kimberly-clark-worth-nearly-3-million
Slocum Gordon & Co LLP sold all 20,789 shares of Kimberly-Clark Corp, valued at approximately $2.96 million, reducing their position to zero as of June 30, 2025. The company's top holdings after the filing include Procter & Gamble, NextEra Energy, Exxon Mobil, and Merck. Kimberly-Clark's shares have underperformed the S&P 500 over the past year, with a 1-year price drop of 8.46%. The company manufactures and markets personal care and tissue products under brands such as Huggies, Kleenex, and Scott.
Title: Slocum Gordon & Co LLP Exits Kimberly-Clark Stake, Reduces Position to ZeroOn August 19, 2025, Slocum, Gordon & Co LLP reported selling all 20,789 shares of Kimberly-Clark Corporation (NASDAQ:KMB) during the second quarter. The estimated transaction value, based on the quarterly average price for Q2 2025, was approximately $2.96 million. This move reduced the fund’s position in Kimberly-Clark to zero as of June 30, 2025.
The top holdings after the filing include Procter & Gamble, NextEra Energy, Exxon Mobil, and Merck. Kimberly-Clark shares were priced at $131.33 as of August 18, 2025, with a 1-year price drop of 8.46%. The shares underperformed the S&P 500 by 23.5 percentage points over this period. The company's dividend yield stands at 3.74%, with a forward P/E ratio of 17.34 and an EV/EBITDA (TTM) of 13.0 (as of 2025-06-30). The shares were down 11.9% from their 52-week high as of 2025-08-18.
Kimberly-Clark manufactures and markets personal care and tissue products under brands such as Huggies, Kleenex, and Scott. The company generates revenue primarily through direct sales to supermarkets, mass merchandisers, drugstores, warehouse clubs, and e-commerce platforms, as well as via distributors for both household and away-from-home use. It serves retail consumers globally and commercial clients in sectors including manufacturing, lodging, office buildings, and food service.
References
[1] https://www.marketbeat.com/stocks/NYSE/T/institutional-ownership/
[2] https://www.nasdaq.com/articles/slocum-gordon-exits-stake-kimberly-clark-worth-nearly-3-million
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet